Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour. - Wikidata - wikimedia - TriplyDB

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.

http://www.wikidata.org/entity/Q35208183

about

A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy Pegfilgrastim for the prevention of chemotherapy-induced febrile neutropenia in patients with solid tumors.Adolescents and young adults with a "rare" cancer: getting past semantics to optimal care for patients with germ cell tumors Urologic oncology: Poor trial accrual hinders germ cell tumor therapy advances.Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).Long-term outcomes of accelerated BEP (bleomycin, etoposide, cisplatin) for advanced germ cell tumours: updated analysis of an Australian multicentre phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP

P2860

Q35540049-4D23457B-A36D-4146-B1E9-FB42696045A8 Q36126134-89326359-631E-4584-BD89-821BD44C002B Q36179016-77BD8417-853C-464B-8CD9-97A9364B5A0E Q38613025-AD00905B-D8DE-4A66-8A21-3F19BB75B8BB Q42716527-45E4D6E2-6ABC-47ED-A940-8A3BE72F6C9C Q43674058-FBE66C09-AC56-4D9B-A3D1-2678A86DFEC4 Q44435533-C6B15B73-151D-4C1C-9A11-5658AEB7B09F Q53041289-DA4D7710-5AF9-4F98-88BA-3ECD2C117A51

P2860

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour.

http://www.wikidata.org/entity/Q35208183

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@ast

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@en

type

label

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@ast

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@en

prefLabel

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@ast

Accelerated BEP: a phase I tri ...... s metastatic germ cell tumour.

@en

P1433

Q35208183-DFC1EFC6-A6D6-4940-ACAE-03B1447F63CB

P1476

Q35208183-F8362C4E-B50F-43AD-B366-A443E3FAB7FE

P2093

Q35208183-0FD6245E-FCAB-4DDE-A907-2232879EA925

Q35208183-121E2C9F-9D14-451F-B924-EE17D3150B82

Q35208183-299FBC33-6407-4ED7-9503-C606EA5FF47B

Q35208183-42473F3C-D3FD-4772-BCF7-6F77E64D447F

Q35208183-4EA1C8C3-721C-47FF-A4F8-0F6EFB6F8B09

Q35208183-6CD99118-6848-4355-A736-5A08BCF8ED0F

Q35208183-A4C3E111-FDAE-4B68-AF17-DFB8B669D16B

Q35208183-DC6B7CB1-82B6-4AC7-8D7E-D14029E90DE3

Q35208183-EF6CDD92-0160-48B5-8E20-185154E5C825

Q35208183-F3EA1A92-A1C5-445B-8A9C-D813330D9263

P2860

Q35208183-075D83B7-61E1-435D-8BFF-219450BD1B55

Q35208183-13FD64AA-2A6E-4091-855F-25E24850B90A

Q35208183-1A981B4E-39DB-452E-9564-FC17FBFA5647

Q35208183-31626BB8-6D61-4F3E-ACE3-76372903BE43

Q35208183-47E31F5D-0877-4AE2-A80D-177E11ABAAFD

Q35208183-4B0DFB72-EEFA-4660-A6CE-1D5C5471B2F2

Q35208183-4B360C3E-9C22-466E-B21B-F30568BB8214

Q35208183-4D752684-3C78-4A2B-B554-C765BBC91E72

Q35208183-575FCBF7-EF57-49E1-ADAE-F1D24B8532F5

Q35208183-6011911D-134C-48A2-AD13-C3A23C9A6EAB

P2888

Q35208183-4A87A60B-2F76-47BC-861D-2ED752F87DE0

P304

Q35208183-5189BA25-BF57-4FF2-B4E7-B0B284A75266

P31

Q35208183-ADEAF7E6-FE08-40F5-BA98-7765CD53393D

P356

Q35208183-BCD011C6-E20C-48A9-8FA8-2E7300F09448

P407

Q35208183-A0D4350B-149D-4A7C-93FF-B0CF4D171D42

P433

Q35208183-6FCCA8A0-EC19-470C-BADC-B8AFC133E9D1

P478

Q35208183-358194BB-8AEB-4A23-970B-A76C2E2F5CA5

P50

Q35208183-CC96ACF0-8B82-4A94-8574-D1FC3D8C7FF3

Q35208183-F67D78C3-FD0A-4D3B-A06D-64019B918FEE

P577

Q35208183-3B9275E8-9B6C-4BB9-AFD2-8249BAA9FB5E

P5875

Q35208183-953ACD23-FC95-4106-B625-611E2E1AF407

P698

Q35208183-F5658136-52A7-4F20-9A76-B018211D19B4

P921

Q35208183-BC813466-10A6-4C49-A9B2-59DFCCFE3548

P932

Q35208183-AD20CE07-760F-4220-B25A-CE397D349746

P356

P1433

British Journal of Cancer

P1476

Accelerated BEP: a phase I tri ...... is metastatic germ cell tumour

@en

P2093

D Mazhar

http://www.w3.org/2001/XMLSchema#string

D Stark

http://www.w3.org/2001/XMLSchema#string

G Armstrong

http://www.w3.org/2001/XMLSchema#string

J Chester

http://www.w3.org/2001/XMLSchema#string

J Joffe

http://www.w3.org/2001/XMLSchema#string

J Shamash

http://www.w3.org/2001/XMLSchema#string

J White

http://www.w3.org/2001/XMLSchema#string

M V Williams

http://www.w3.org/2001/XMLSchema#string

T Powles

http://www.w3.org/2001/XMLSchema#string

Y Rimmer

http://www.w3.org/2001/XMLSchema#string

P2860

Dose-dense adjuvant chemotherapy for primary breast cancer.

Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Ran

Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.

Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).

Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms.

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germin

Intensive induction chemotherapy with CBOP/BEP in patients with poor prognosis germ cell tumors.

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Ca

GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.

P2888

P304

766-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2011.309

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51576556

http://www.w3.org/2001/XMLSchema#string

P698

21847130

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

3171015

http://www.w3.org/2001/XMLSchema#string